Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections
Public ClinicalTrials.gov record NCT05472779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections: TAPER (Techniques of APplying Vaginal Estrogen for Prevention of Recurrent Urinary Tract Infections) Trial
Study identification
- NCT ID
- NCT05472779
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Stephanie Wang Zuo
- Other
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Interventions
- Intravaginal application of estradiol cream Drug
- Periurethral application of estradiol cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2023
- Primary completion
- Jun 14, 2025
- Completion
- Jun 24, 2025
- Last update posted
- Jul 7, 2025
2023 – 2025
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UPMC Lemieux Sports Complex | Cranberry Township | Pennsylvania | 16066 | — |
| UPMC Hamot | Erie | Pennsylvania | 16550 | — |
| University of Pittsburgh Medical Center-Magee Womens Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| UPMC Passavant-McCandless | Pittsburgh | Pennsylvania | 15237 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05472779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2025 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05472779 live on ClinicalTrials.gov.